Multimeric recombinant M2e protein-based ELISA: A significant improvement in differentiating avian influenza infected chickens from vaccinated ones

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Hadifar, Farshid ^a   Ignjatovic, Jagoda ^b   Tarigan, Simson ^c   Indriani, Risa ^c   Ebrahimie, Esmaeil ^a   Haliza Hasan, Noor ^a   McWhorter, Andrea ^a   Putland, Sophie ^a   Ownagh, Abdulghaffar ^d   Hemmatzadeh, Farhid ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Indonesian Research Centre for Veterinary Science   (Indonesia)

^d URMIA UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; MALTOSE BINDING PROTEIN; MATRIX PROTEIN; MATRIX PROTEIN 2E; RECOMBINANT M2E PROTEIN; RECOMBINANT PROTEIN; TETRAMER; UNCLASSIFIED DRUG; HYBRID PROTEIN; M2 PROTEIN, INFLUENZA A VIRUS; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TM2E GENE; VIRUS ISOLATION; VIRUS STRAIN; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMISTRY; CHICKEN; GENE VECTOR; GENETICS; IMMUNOLOGY; INFLUENZA IN BIRDS; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; PROCEDURES; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; VIROLOGY;

AVES; GALLUS GALLUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BLOTTING, WESTERN; CHICKENS; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS;

EID: 84908032160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108420     Document Type: Article

References (25)

1. Fiebig L, Soyka J, Buda S, Buchholz U, Dehnert M, et al. (2011) Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill 16.
2. Kelly TR, Hawkins MG, Sandrock CE, Boyce WM (2008) A review of highly pathogenic avian influenza in birds, with an emphasis on Asian H5N1 and recommendations for prevention and control. Journal of avian medicine and surgery 22: 1-16.
3. Webster RG, Govorkova EA (2006) H5N1 influenza - continuing evolution and spread. New England Journal of Medicine 355: 2174-2177.
4. Swayne D, Pantin-Jackwood M (2005) Pathogenicity of avian influenza viruses in poultry. Developments in biologicals 124: 61-67.
5. World Health Organization/World Organisation for Animal HF, Agriculture Organization HNEWG (2014) Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses 8: 384-388.
6. Zaman M, Gasimov V, Oner AF, Dogan N, Adisasmito W, et al. (2014) Recognizing true H5N1 infections in humans during confirmed outbreaks. J Infect Dev Ctries 8: 202-207.
7. Adisasmito W, Aisyah DN, Aditama TY, Kusriastuti R, Trihono, et al. (2013) Human influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiation. BMC Public Health 13: 571.
8. Jennings LC (2013) Influenza vaccines: an Asia-Pacific perspective. Influenza Other Respir Viruses 7 Suppl 3: 44-51.
9. Du L, Zhou Y, Jiang S (2010) Research and development of universal influenza vaccines. Microbes and infection 12: 280-286.
10. Swayne DE (2012) Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 56: 818-828.
11. Kosasih H, Roselinda Nurhayati, Klimov A, Xiyan X, et al. (2013) Surveillance of influenza in Indonesia, 2003-2007. Influenza Other Respir Viruses 7: 312-320.
12. Suarez DL (2005) Overview of avian influenza DIVA test strategies. Biologicals 33: 221-226.
13. Escorcia M, Vazquez L, Mendez ST, Rodriguez-Ropon A, Lucio E, et al. (2008) Avian influenza: genetic evolution under vaccination pressure. Virol J 5: 15.
14. Robles F, Uribe A, Guadarrama A, Castellanos L, González C (2010) Implementation of a "DIVA" Concept with specific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is used. World Academy of Science, Engineering and Technology 41: 4.
15. Hemmatzadeh F, Sumarningsih S, Tarigan S, Indriani R, Dharmayanti NI, et al. (2013) Recombinant M2e protein-based ELISA: A novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones. PloS one 8: e56801.
16. Lambrecht B, Steensels M, Van Borm S, Meulemans G, Van den Berg T (2007) Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian diseases 51: 221-226.
17. Uversky V, Longhi S (2011) Flexible viruses: structural disorder in viral proteins: John Wiley & Sons.
18. Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, et al. (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26: 201-214.
19. Watanabe T, Watanabe S, Kim JH, Hatta M, Kawaoka Y (2008) Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. Journal of virology 82: 2486-2492.
20. Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T (2007) Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis 51: 221-226.
21. Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, et al. (2006) Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virology journal 3: 102.
22. Lee YN, Kim MC, Lee YT, Hwang HS, Cho MK, et al. (2014) AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection. Vaccine.
23. Jegerlehner A, Schmitz N, Storni T, Bachmann MF (2004) Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. The Journal of Immunology 172: 5598-5605.
24. Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual: Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York.
25. Greiner M (1995) Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests. Journal of immunological methods 185: 2.